LISATA THERAPEUTICS, INC. Annual Amortization of Intangible Assets in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Lisata Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2010 to 2023.
  • Lisata Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $18K, unchanged year-over-year.
  • Lisata Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $20K.
  • Lisata Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $21K, unchanged from 2022.
  • Lisata Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $21K.
  • Lisata Therapeutics, Inc. annual Amortization of Intangible Assets for 2016 was $570K, a 5.82% decline from 2015.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $21K $0 0% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $21K Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2016 $570K -$35.2K -5.82% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-17
2015 $605K $0 0% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-17
2014 $605K $0 0% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 $605K $0 0% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $605K +$27.9K +4.83% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $577K +$542K +1540% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-11
2010 $35.2K Jan 1, 2010 Dec 31, 2010 8-K 2012-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.